Oxcarbazepine shortage — US supply status & alternatives

Oxcarbazepine

—

🇦🇺 AUST R 76200 · Novartis Pharmaceuticals Australia Pty Ltd

In supply · Australia

Jamp-Oxcarbazepine

In supply · 🇦🇺 Australia · short in🇺🇸 US🇨🇦 CA🇩🇪 DE

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$40.20DPMQ A$185.48details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes

reference data we hold

Active ingredient (INN)	Oxcarbazepine
Brand names	Jamp-Oxcarbazepine
Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper
Controlled substance	No
Marketing-authorisation holders	Generics (UK) Limited, MORNINGSIDE HEALTHCARE LIMITED, CRESCENT PHARMA LIMITED, NOVARTIS IRELAND LIMITED +4 more
Registrations on file	22
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$40.20

AEMP

Dispensed (DPMQ)

A$185.48

incl. fees

Pack

oxcarbazepine 60 mg/mL oral liquid, 250 mL

Source: PBSEffective July 2026 · AUD

Other markets

🇬🇧 GB

£5.79

Drug Tariff

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 1 resolved event

◷

~3 months

Historical pattern from resolved shortage records — not a prediction of this event.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

18 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Micro Labs LTDZaklady Farmaceutyczne Polpharma SAAmi Lifesciences Private LTDMsn Life Sciences Private LTDTaro Pharmaceutical Industries LTDJubilant Biosys LTD+12 more

Manufacturing countries: India, Poland, Israel, Italy, China · Source: FDA List of Drug Master Files

FDA-approved products 🇺🇸 Drugs@FDA

Approved applications

Generic (ANDA)

Brand (NDA/BLA)

Nov 2024

Latest approval

Shortage status by regulator official notices

🇺🇸

United States

ANSM Ruptures · 3mo ago

High

🇨🇦

Canada

HC · 1h ago

Medium

🇩🇪

Germany

BfArM · 10h ago

Medium

🇬🇷

EOF · 1mo ago

Resolved

Recalls official enforcement reports

🇺🇸

Oxcarbazepine Oral Suspension

Akorn, Inc. · Apr 2023

Class IIdetails ↗

🇺🇸

OXCARBAZEPINE

SUN PHARMACEUTICAL INDUSTRIES INC · Dec 2022

Class IIdetails ↗

🇺🇸

Oxcarbazepine Oral Suspension

West-Ward Columbus Inc · Sept 2019

Class IIdetails ↗

🇺🇸

Oxcarbazepine Active Pharmaceutical Ingredient Packaged In V

Attix Pharmaceuticals · Nov 2014

Class IIdetails ↗

🇺🇸

Oxcarbazepine Tablets

American Health Packaging · July 2014

Class Idetails ↗

🇺🇸

OXCARBAZEPINE

Caraco Pharmaceutical Laboratories Ltd. · Jan 2014

Class IIdetails ↗

Verified timeline regulator events

🇬🇷 19 Feb 2026

Shortage resolved

🇩🇪 9 May 2025

medium reported

🇺🇸 26 Apr 2023

high reported

🇨🇦 12 Oct 2018

medium reported

🇺🇸 1 July 2014

high reported

Sources official regulators

🇨🇦

verified 1h ago

verify ↗

🇩🇪

BfArM

verified 10h ago

verify ↗

🇺🇸

ANSM Ruptures

verified 3mo ago

verify ↗

🇬🇷

EOF

verified 1mo ago

verify ↗

🇺🇸

FDA MedWatch

verified 4mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders22 registrations · 8 MA holders

Product	Strength	Form	Market	MA holder	Status
Oxcarbazepine Mylan	150MG	tablet	🇬🇧 GB	Generics (UK) Limited	Active
Oxcarbazepine Mylan	300MG	tablet	🇬🇧 GB	Generics (UK) Limited	Active
Oxcarbazepine Mylan	600MG	tablet	🇬🇧 GB	Generics (UK) Limited	Active
Oxcarbazepine Morningside	300 MG	tablet	🇬🇧 GB	MORNINGSIDE HEALTHCARE LIMITED	Active
Oxcarbazepine Morningside	600 MG	tablet	🇬🇧 GB	MORNINGSIDE HEALTHCARE LIMITED	Active
OXCARBAZEPINE 150 MG FILM COATED TABLETS	150 MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
OXCARBAZEPINE 300 MG FILM COATED TABLETS	300 MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
OXCARBAZEPINE 600 MG FILM COATED TABLETS	600 MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
OXCARBAZEPINE 150 MG FILM-COATED TABLETS	150 MG	tablet	🇬🇧 GB	NOVARTIS IRELAND LIMITED	Active
OXCARBAZEPINE 300 MG FILM-COATED TABLETS	300 MG	tablet	🇬🇧 GB	NOVARTIS IRELAND LIMITED	Active
OXCARBAZEPINE 600 MG FILM-COATED TABLETS	600 MG	tablet	🇬🇧 GB	NOVARTIS IRELAND LIMITED	Active
Oxcarbazepine Amarox	150 MG	tablet	🇬🇧 GB	AMAROX LIMITED	Active
Oxcarbazepine Amarox	300 MG	tablet	🇬🇧 GB	AMAROX LIMITED	Active
Oxcarbazepine Amarox	600 MG	tablet	🇬🇧 GB	AMAROX LIMITED	Active
TRILEPTAL oxcarbazepine	150mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active

+7 more registrations on file

Mederti Drug Report

Generated 5 July 2026 · Australia market · 5 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.